Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07119827

Personality Traits as a Variable in the Recovery of Patients With Acquired Brain Injury

Neuropsychology and Personality: Personality Traits as a Variable in the Recovery of Patients With Acquired Brain Injury

Status
Recruiting
Phase
Study type
Observational
Enrollment
250 (estimated)
Sponsor
Universita di Verona · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study aims to evaluate the potential effects of premorbid personality on the short- and long-term global cognitive recovery in patients with severe acquired brain injury (sABI) or stroke. The secondary aims are to assess the effects of premorbid personality on the sort- and long-term recovery in autonomy (disability), cognitive functions, psycho-behavioral functioning, motor skills, and social participation. Evaluate the incidence of premorbid personality alterations. Investigate personality changes 12-18 months after the neurological event.

Detailed description

Participants included in the study will undergo cognitive, motor, psychological, behavioral, personality, and disability assessments at different time points following the neurological event: T0: Initial assessment upon admission to the rehabilitation facility; within 90 days of the event for patients with severe acquired brain injury (sABI), as soon as cognitive evaluation becomes feasible (LCF ≥ 6); within 30 days of the event for stroke patients, as soon as cognitive assessment is possible. T1: At discharge from the inpatient rehabilitation program, provided that at least 30 days have passed since the initial assessment (T0). T2: At 12 months post-event for stroke patients and at 18 months post-event for patients with ABI.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMotor, cognitive and psychological assessmentParticipants evaluated at T0 (Initial assessment upon admission to the rehabilitation facility), T1 (at discharge from the inpatient rehabilitation program, as long as at least 30 days have passed since the initial assessment (T0), T2 (at 12 months from the event for patients with stroke, and at 18 months from the event for patients with sABI).

Timeline

Start date
2025-05-01
Primary completion
2028-05-01
Completion
2028-05-01
First posted
2025-08-13
Last updated
2025-08-13

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT07119827. Inclusion in this directory is not an endorsement.